Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir-Reference-Cited by-同舟云学术

Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir

Published:2018-07 Issue:7 Volume:113 Page:998-1008
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Shin Jung Woo,Jung Seok Won,Lee Seung Bum,Lee Byung Uk,Park Bo Ryung,Park Eun Ji,Park Neung Hwa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/s41395-018-0093-9.pdf

Reference35 articles.

1. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.;Ott;Vaccine,2012

2. Epidemiology of viral hepatitis and hepatocellular carcinoma.;El-Serag;Gastroenterology,2012

3. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.;Sarin;Hepatol Int,2016

4. The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy.;Varbobitis;Clin Mol Hepatol,2016

5. Long-term entecavir therapy results in the reversal of fibrosiscirrhosis and continued histological improvement in patients with chronic hepatitis B.;Chang;Hepatology,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-07

2. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?;Current Hepatology Reports;2024-02-12

3. Finite therapy of chronic hepatitis B infection: Pros;Clinical Liver Disease;2024-01

4. Progress of Research on the Current Status and Influencing Factors of Medication Adherence in Chronic Hepatitis B Patients;Advances in Clinical Medicine;2024

5. Liver Carcinogenesis Suppression in Chronic Hepatitis B in the Nucleoside Analogues Era;In Vivo;2023-12-25